DiaMedica Therapeutics (DMAC)
(Delayed Data from NSDQ)
$3.15 USD
+0.03 (1.07%)
Updated May 13, 2024 12:03 PM ET
2-Buy of 5 2
D Value F Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/12/24 |
---|---|
Current Quarter | -0.16 |
EPS Last Quarter | -0.14 |
Last EPS Surprise | 12.50% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.69 |
Next Year | NA |
EPS (TTM) | -0.56 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.16 | -0.18 | -0.69 | NA |
# of Estimates | 1 | 1 | 1 | NA |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | -0.16 | -0.18 | -0.69 | NA |
Low Estimate | -0.16 | -0.18 | -0.69 | NA |
Year ago EPS | -0.16 | -0.12 | -0.60 | -0.69 |
Year over Year Growth Est. | 0.00% | -50.00% | -15.00% | NA |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | NA |
Up Last 30 Days | 0 | 0 | 0 | NA |
Up Last 60 Days | 1 | 1 | 1 | NA |
Down Last 7 Days | 0 | 0 | 0 | NA |
Down Last 30 Days | 0 | 0 | 0 | NA |
Down Last 60 Days | 0 | 0 | 0 | NA |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.16 | -0.18 | -0.69 | NA |
7 Days Ago | -0.16 | -0.18 | -0.69 | NA |
30 Days Ago | -0.16 | -0.18 | -0.69 | NA |
60 Days Ago | -0.17 | -0.20 | -0.74 | NA |
90 Days Ago | -0.17 | -0.20 | -0.74 | NA |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.16 | -0.18 | -0.69 | NA |
Zacks Consensus Estimate | -0.16 | -0.18 | -0.69 | NA |
Earnings ESP | 0.00% | 0.00% | 0.00% | NA |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.14 | -0.14 | -0.12 | -0.16 | NA |
Estimate | -0.16 | -0.14 | -0.14 | -0.22 | NA |
Difference | 0.02 | 0.00 | 0.02 | 0.06 | 0.03 |
Surprise | 12.50% | 0.00% | 14.29% | 27.27% | 13.52% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more